Nasal High-Flow device tested for breathing trouble

NCT ID NCT06008587

Terminated Symptom relief Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a device that delivers warm, moist air through the nose to help people with breathing failure who did not have too much acid in their blood. The goal was to see if it could prevent their condition from getting worse. Only 16 people took part, and the study was stopped early, so the results are not strong enough to draw clear conclusions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Nasal high-flow device (AIRVO3 TM)
What this could lead to: If it works, this could offer a gentler breathing support option for some patients with respiratory failure.
What could go wrong: The trial was terminated early with only 16 participants, so results are very limited. It is unclear if the device helps more than standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERCAPNIC ACUTE RESPIRATORY FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute respiratory failure Hypercapnia respiratory failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RESPIRATORY INSUFFICIENCY

Contacts and locations

Locations

Centre Hospitalier Intercommunal de Toulon- La Seyne sur Mer - Hôpital Sainte Musse

Toulon, Var, 83100, France
Centre Hospitalier Princesse Grace

Monaco, 98000, Monaco
Centre Hospitalier de Cannes

Cannes, Alpes Maritime, 06400, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.